Company intelligence / Profile preview

Kephera Diagnostics

Framingham, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Kephera Diagnostics is a biotech startup developing point-of-care and ELISA immunoassays for infectious diseases. The company has launched its first blood test for endometriosis and developed a serologic test for Lyme disease with >90% sensitivity in early stage patients. Kephera collaborates with global researchers to translate new technologies into accessible diagnostic products.

Therapeutic areas: Women's HealthInfectious Diseases
Modalities: ImmunoassayDevice
Industry: Protein Biomarker Diagnostics

Partnerships

Global network of researchers

Beyond the preview

Go deeper on Kephera Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kephera Diagnostics.

Explore the full profile